nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—ABCB1—peripheral nervous system neoplasm	0.225	1	CbGaD
Clonidine—SLC22A3—Melphalan—peripheral nervous system neoplasm	0.169	0.301	CbGbCtD
Clonidine—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.0505	0.0897	CbGbCtD
Clonidine—SLC22A3—Vincristine—peripheral nervous system neoplasm	0.0501	0.089	CbGbCtD
Clonidine—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.044	0.0782	CbGbCtD
Clonidine—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0378	0.0672	CbGbCtD
Clonidine—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0264	0.0469	CbGbCtD
Clonidine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0211	0.0376	CbGbCtD
Clonidine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0185	0.0328	CbGbCtD
Clonidine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0185	0.0328	CbGbCtD
Clonidine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0169	0.03	CbGbCtD
Clonidine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0128	0.0228	CbGbCtD
Clonidine—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0121	0.0215	CbGbCtD
Clonidine—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0111	0.0197	CbGbCtD
Clonidine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0111	0.0197	CbGbCtD
Clonidine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0103	0.0183	CbGbCtD
Clonidine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00827	0.0147	CbGbCtD
Clonidine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00789	0.014	CbGbCtD
Clonidine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00736	0.0131	CbGbCtD
Clonidine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00723	0.0128	CbGbCtD
Clonidine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00493	0.00876	CbGbCtD
Clonidine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00473	0.0084	CbGbCtD
Clonidine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00465	0.00826	CbGbCtD
Clonidine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00433	0.0077	CbGbCtD
Clonidine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00295	0.00525	CbGbCtD
Clonidine—NISCH—Podofilox—Etoposide—peripheral nervous system neoplasm	0.00185	0.592	CbGdCrCtD
Clonidine—NISCH—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.00127	0.408	CbGdCrCtD
Clonidine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000119	0.000617	CcSEcCtD
Clonidine—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000616	CcSEcCtD
Clonidine—Rash—Melphalan—peripheral nervous system neoplasm	0.000119	0.000615	CcSEcCtD
Clonidine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000119	0.000615	CcSEcCtD
Clonidine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000118	0.000613	CcSEcCtD
Clonidine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000118	0.00061	CcSEcCtD
Clonidine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000609	CcSEcCtD
Clonidine—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000609	CcSEcCtD
Clonidine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000118	0.000609	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000117	0.000606	CcSEcCtD
Clonidine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000116	0.000603	CcSEcCtD
Clonidine—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000603	CcSEcCtD
Clonidine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000115	0.000597	CcSEcCtD
Clonidine—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000597	CcSEcCtD
Clonidine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000115	0.000596	CcSEcCtD
Clonidine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000115	0.000595	CcSEcCtD
Clonidine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000114	0.000592	CcSEcCtD
Clonidine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000114	0.000592	CcSEcCtD
Clonidine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000114	0.000592	CcSEcCtD
Clonidine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000114	0.000591	CcSEcCtD
Clonidine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000114	0.00059	CcSEcCtD
Clonidine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000113	0.000587	CcSEcCtD
Clonidine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000113	0.000587	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000112	0.000582	CcSEcCtD
Clonidine—Infection—Etoposide—peripheral nervous system neoplasm	0.000112	0.000581	CcSEcCtD
Clonidine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000112	0.00058	CcSEcCtD
Clonidine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000112	0.00058	CcSEcCtD
Clonidine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000577	CcSEcCtD
Clonidine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000111	0.000573	CcSEcCtD
Clonidine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000111	0.000573	CcSEcCtD
Clonidine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00011	0.000571	CcSEcCtD
Clonidine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00011	0.000571	CcSEcCtD
Clonidine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00011	0.000571	CcSEcCtD
Clonidine—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.00057	CcSEcCtD
Clonidine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00011	0.000569	CcSEcCtD
Clonidine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00011	0.000568	CcSEcCtD
Clonidine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000109	0.000566	CcSEcCtD
Clonidine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000564	CcSEcCtD
Clonidine—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000564	CcSEcCtD
Clonidine—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000558	CcSEcCtD
Clonidine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000108	0.000558	CcSEcCtD
Clonidine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000107	0.000555	CcSEcCtD
Clonidine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000107	0.000553	CcSEcCtD
Clonidine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000107	0.000552	CcSEcCtD
Clonidine—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000552	CcSEcCtD
Clonidine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000107	0.000551	CcSEcCtD
Clonidine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000106	0.000547	CcSEcCtD
Clonidine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000106	0.000546	CcSEcCtD
Clonidine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000539	CcSEcCtD
Clonidine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000104	0.000538	CcSEcCtD
Clonidine—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000536	CcSEcCtD
Clonidine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000534	CcSEcCtD
Clonidine—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000533	CcSEcCtD
Clonidine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000103	0.000532	CcSEcCtD
Clonidine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000102	0.00053	CcSEcCtD
Clonidine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000102	0.000526	CcSEcCtD
Clonidine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000101	0.000525	CcSEcCtD
Clonidine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000525	CcSEcCtD
Clonidine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000101	0.000522	CcSEcCtD
Clonidine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.0001	0.00052	CcSEcCtD
Clonidine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.0001	0.000518	CcSEcCtD
Clonidine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	9.93e-05	0.000514	CcSEcCtD
Clonidine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	9.93e-05	0.000514	CcSEcCtD
Clonidine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	9.91e-05	0.000513	CcSEcCtD
Clonidine—Rash—Dactinomycin—peripheral nervous system neoplasm	9.85e-05	0.00051	CcSEcCtD
Clonidine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	9.83e-05	0.000509	CcSEcCtD
Clonidine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	9.76e-05	0.000505	CcSEcCtD
Clonidine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	9.75e-05	0.000505	CcSEcCtD
Clonidine—Fatigue—Etoposide—peripheral nervous system neoplasm	9.74e-05	0.000504	CcSEcCtD
Clonidine—Constipation—Etoposide—peripheral nervous system neoplasm	9.67e-05	0.0005	CcSEcCtD
Clonidine—Pain—Etoposide—peripheral nervous system neoplasm	9.67e-05	0.0005	CcSEcCtD
Clonidine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	9.66e-05	0.0005	CcSEcCtD
Clonidine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	9.64e-05	0.000499	CcSEcCtD
Clonidine—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	9.58e-05	0.000496	CcSEcCtD
Clonidine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	9.57e-05	0.000496	CcSEcCtD
Clonidine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	9.55e-05	0.000494	CcSEcCtD
Clonidine—Sweating—Epirubicin—peripheral nervous system neoplasm	9.52e-05	0.000493	CcSEcCtD
Clonidine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	9.52e-05	0.000493	CcSEcCtD
Clonidine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	9.38e-05	0.000486	CcSEcCtD
Clonidine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	9.37e-05	0.000485	CcSEcCtD
Clonidine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	9.31e-05	0.000482	CcSEcCtD
Clonidine—Nausea—Dactinomycin—peripheral nervous system neoplasm	9.28e-05	0.00048	CcSEcCtD
Clonidine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	9.24e-05	0.000478	CcSEcCtD
Clonidine—Dizziness—Vincristine—peripheral nervous system neoplasm	9.23e-05	0.000478	CcSEcCtD
Clonidine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	9.21e-05	0.000477	CcSEcCtD
Clonidine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	9.19e-05	0.000476	CcSEcCtD
Clonidine—Rash—Alitretinoin—peripheral nervous system neoplasm	9.13e-05	0.000473	CcSEcCtD
Clonidine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	9.12e-05	0.000472	CcSEcCtD
Clonidine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	9.09e-05	0.00047	CcSEcCtD
Clonidine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	9.08e-05	0.00047	CcSEcCtD
Clonidine—Headache—Alitretinoin—peripheral nervous system neoplasm	9.07e-05	0.000469	CcSEcCtD
Clonidine—Urticaria—Etoposide—peripheral nervous system neoplasm	8.98e-05	0.000465	CcSEcCtD
Clonidine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	8.94e-05	0.000463	CcSEcCtD
Clonidine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	8.93e-05	0.000462	CcSEcCtD
Clonidine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	8.93e-05	0.000462	CcSEcCtD
Clonidine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	8.93e-05	0.000462	CcSEcCtD
Clonidine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	8.92e-05	0.000462	CcSEcCtD
Clonidine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	8.87e-05	0.000459	CcSEcCtD
Clonidine—Vomiting—Vincristine—peripheral nervous system neoplasm	8.87e-05	0.000459	CcSEcCtD
Clonidine—Asthenia—Cisplatin—peripheral nervous system neoplasm	8.85e-05	0.000458	CcSEcCtD
Clonidine—Sweating—Doxorubicin—peripheral nervous system neoplasm	8.81e-05	0.000456	CcSEcCtD
Clonidine—Rash—Vincristine—peripheral nervous system neoplasm	8.8e-05	0.000455	CcSEcCtD
Clonidine—Dermatitis—Vincristine—peripheral nervous system neoplasm	8.79e-05	0.000455	CcSEcCtD
Clonidine—Headache—Vincristine—peripheral nervous system neoplasm	8.74e-05	0.000452	CcSEcCtD
Clonidine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	8.67e-05	0.000449	CcSEcCtD
Clonidine—Nausea—Alitretinoin—peripheral nervous system neoplasm	8.6e-05	0.000445	CcSEcCtD
Clonidine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	8.44e-05	0.000437	CcSEcCtD
Clonidine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	8.4e-05	0.000435	CcSEcCtD
Clonidine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	8.33e-05	0.000431	CcSEcCtD
Clonidine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	8.33e-05	0.000431	CcSEcCtD
Clonidine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	8.31e-05	0.00043	CcSEcCtD
Clonidine—Nausea—Vincristine—peripheral nervous system neoplasm	8.29e-05	0.000429	CcSEcCtD
Clonidine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	8.28e-05	0.000428	CcSEcCtD
Clonidine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	8.27e-05	0.000428	CcSEcCtD
Clonidine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	8.25e-05	0.000427	CcSEcCtD
Clonidine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.000425	CcSEcCtD
Clonidine—Asthenia—Etoposide—peripheral nervous system neoplasm	8.11e-05	0.00042	CcSEcCtD
Clonidine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	8.09e-05	0.000419	CcSEcCtD
Clonidine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	8.04e-05	0.000416	CcSEcCtD
Clonidine—Pruritus—Etoposide—peripheral nervous system neoplasm	8e-05	0.000414	CcSEcCtD
Clonidine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	7.97e-05	0.000412	CcSEcCtD
Clonidine—Alopecia—Epirubicin—peripheral nervous system neoplasm	7.88e-05	0.000408	CcSEcCtD
Clonidine—Vomiting—Cisplatin—peripheral nervous system neoplasm	7.84e-05	0.000406	CcSEcCtD
Clonidine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	7.81e-05	0.000404	CcSEcCtD
Clonidine—Rash—Cisplatin—peripheral nervous system neoplasm	7.78e-05	0.000403	CcSEcCtD
Clonidine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	7.77e-05	0.000402	CcSEcCtD
Clonidine—Erythema—Epirubicin—peripheral nervous system neoplasm	7.76e-05	0.000402	CcSEcCtD
Clonidine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	7.73e-05	0.0004	CcSEcCtD
Clonidine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	7.71e-05	0.000399	CcSEcCtD
Clonidine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	7.69e-05	0.000398	CcSEcCtD
Clonidine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.000396	CcSEcCtD
Clonidine—Tension—Epirubicin—peripheral nervous system neoplasm	7.62e-05	0.000394	CcSEcCtD
Clonidine—Nervousness—Epirubicin—peripheral nervous system neoplasm	7.54e-05	0.00039	CcSEcCtD
Clonidine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	7.49e-05	0.000387	CcSEcCtD
Clonidine—Dizziness—Etoposide—peripheral nervous system neoplasm	7.47e-05	0.000387	CcSEcCtD
Clonidine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.000386	CcSEcCtD
Clonidine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.44e-05	0.000385	CcSEcCtD
Clonidine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	7.37e-05	0.000382	CcSEcCtD
Clonidine—Nausea—Cisplatin—peripheral nervous system neoplasm	7.33e-05	0.000379	CcSEcCtD
Clonidine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	7.32e-05	0.000379	CcSEcCtD
Clonidine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	7.29e-05	0.000377	CcSEcCtD
Clonidine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	7.23e-05	0.000374	CcSEcCtD
Clonidine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	7.2e-05	0.000373	CcSEcCtD
Clonidine—Vomiting—Etoposide—peripheral nervous system neoplasm	7.19e-05	0.000372	CcSEcCtD
Clonidine—Erythema—Doxorubicin—peripheral nervous system neoplasm	7.18e-05	0.000372	CcSEcCtD
Clonidine—Agitation—Epirubicin—peripheral nervous system neoplasm	7.13e-05	0.000369	CcSEcCtD
Clonidine—Rash—Etoposide—peripheral nervous system neoplasm	7.13e-05	0.000369	CcSEcCtD
Clonidine—Dermatitis—Etoposide—peripheral nervous system neoplasm	7.12e-05	0.000369	CcSEcCtD
Clonidine—Headache—Etoposide—peripheral nervous system neoplasm	7.08e-05	0.000366	CcSEcCtD
Clonidine—Tension—Doxorubicin—peripheral nervous system neoplasm	7.05e-05	0.000365	CcSEcCtD
Clonidine—Malaise—Epirubicin—peripheral nervous system neoplasm	7e-05	0.000362	CcSEcCtD
Clonidine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	6.98e-05	0.000361	CcSEcCtD
Clonidine—Syncope—Epirubicin—peripheral nervous system neoplasm	6.96e-05	0.00036	CcSEcCtD
Clonidine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	6.91e-05	0.000357	CcSEcCtD
Clonidine—Palpitations—Epirubicin—peripheral nervous system neoplasm	6.86e-05	0.000355	CcSEcCtD
Clonidine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	6.82e-05	0.000353	CcSEcCtD
Clonidine—Cough—Epirubicin—peripheral nervous system neoplasm	6.77e-05	0.000351	CcSEcCtD
Clonidine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	6.77e-05	0.00035	CcSEcCtD
Clonidine—Nausea—Etoposide—peripheral nervous system neoplasm	6.71e-05	0.000347	CcSEcCtD
Clonidine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	6.66e-05	0.000345	CcSEcCtD
Clonidine—Chest pain—Epirubicin—peripheral nervous system neoplasm	6.61e-05	0.000342	CcSEcCtD
Clonidine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	6.61e-05	0.000342	CcSEcCtD
Clonidine—Agitation—Doxorubicin—peripheral nervous system neoplasm	6.6e-05	0.000342	CcSEcCtD
Clonidine—Anxiety—Epirubicin—peripheral nervous system neoplasm	6.59e-05	0.000341	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	6.56e-05	0.00034	CcSEcCtD
Clonidine—Discomfort—Epirubicin—peripheral nervous system neoplasm	6.53e-05	0.000338	CcSEcCtD
Clonidine—Malaise—Doxorubicin—peripheral nervous system neoplasm	6.48e-05	0.000335	CcSEcCtD
Clonidine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	6.46e-05	0.000335	CcSEcCtD
Clonidine—Syncope—Doxorubicin—peripheral nervous system neoplasm	6.44e-05	0.000333	CcSEcCtD
Clonidine—Confusional state—Epirubicin—peripheral nervous system neoplasm	6.39e-05	0.000331	CcSEcCtD
Clonidine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	6.35e-05	0.000329	CcSEcCtD
Clonidine—Oedema—Epirubicin—peripheral nervous system neoplasm	6.34e-05	0.000328	CcSEcCtD
Clonidine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	6.31e-05	0.000327	CcSEcCtD
Clonidine—Infection—Epirubicin—peripheral nervous system neoplasm	6.29e-05	0.000326	CcSEcCtD
Clonidine—Cough—Doxorubicin—peripheral nervous system neoplasm	6.27e-05	0.000324	CcSEcCtD
Clonidine—Shock—Epirubicin—peripheral nervous system neoplasm	6.23e-05	0.000323	CcSEcCtD
Clonidine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	6.21e-05	0.000322	CcSEcCtD
Clonidine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	6.2e-05	0.000321	CcSEcCtD
Clonidine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	6.18e-05	0.00032	CcSEcCtD
Clonidine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	6.15e-05	0.000319	CcSEcCtD
Clonidine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	6.12e-05	0.000317	CcSEcCtD
Clonidine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	6.12e-05	0.000317	CcSEcCtD
Clonidine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	6.12e-05	0.000317	CcSEcCtD
Clonidine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	6.09e-05	0.000315	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	6.07e-05	0.000314	CcSEcCtD
Clonidine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	6.04e-05	0.000313	CcSEcCtD
Clonidine—Anorexia—Epirubicin—peripheral nervous system neoplasm	6.04e-05	0.000313	CcSEcCtD
Clonidine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	5.98e-05	0.00031	CcSEcCtD
Clonidine—Hypotension—Epirubicin—peripheral nervous system neoplasm	5.92e-05	0.000306	CcSEcCtD
Clonidine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	5.91e-05	0.000306	CcSEcCtD
Clonidine—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.86e-05	0.000303	CcSEcCtD
Clonidine—Infection—Doxorubicin—peripheral nervous system neoplasm	5.82e-05	0.000301	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.77e-05	0.000299	CcSEcCtD
Clonidine—Shock—Doxorubicin—peripheral nervous system neoplasm	5.77e-05	0.000299	CcSEcCtD
Clonidine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	5.75e-05	0.000298	CcSEcCtD
Clonidine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	5.74e-05	0.000297	CcSEcCtD
Clonidine—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.73e-05	0.000297	CcSEcCtD
Clonidine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	5.72e-05	0.000296	CcSEcCtD
Clonidine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	5.69e-05	0.000295	CcSEcCtD
Clonidine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.69e-05	0.000294	CcSEcCtD
Clonidine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.67e-05	0.000293	CcSEcCtD
Clonidine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	5.65e-05	0.000292	CcSEcCtD
Clonidine—Somnolence—Epirubicin—peripheral nervous system neoplasm	5.63e-05	0.000292	CcSEcCtD
Clonidine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	5.59e-05	0.000289	CcSEcCtD
Clonidine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.51e-05	0.000285	CcSEcCtD
Clonidine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	5.48e-05	0.000284	CcSEcCtD
Clonidine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	5.47e-05	0.000283	CcSEcCtD
Clonidine—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.46e-05	0.000283	CcSEcCtD
Clonidine—Pain—Epirubicin—peripheral nervous system neoplasm	5.42e-05	0.00028	CcSEcCtD
Clonidine—Constipation—Epirubicin—peripheral nervous system neoplasm	5.42e-05	0.00028	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.34e-05	0.000276	CcSEcCtD
Clonidine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.3e-05	0.000274	CcSEcCtD
Clonidine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.26e-05	0.000272	CcSEcCtD
Clonidine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	5.23e-05	0.000271	CcSEcCtD
Clonidine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.22e-05	0.00027	CcSEcCtD
Clonidine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.00027	CcSEcCtD
Clonidine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	5.18e-05	0.000268	CcSEcCtD
Clonidine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	5.1e-05	0.000264	CcSEcCtD
Clonidine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.06e-05	0.000262	CcSEcCtD
Clonidine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5.05e-05	0.000262	CcSEcCtD
Clonidine—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.03e-05	0.000261	CcSEcCtD
Clonidine—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.01e-05	0.000259	CcSEcCtD
Clonidine—Pain—Doxorubicin—peripheral nervous system neoplasm	5.01e-05	0.000259	CcSEcCtD
Clonidine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.01e-05	0.000259	CcSEcCtD
Clonidine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.01e-05	0.000259	CcSEcCtD
Clonidine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.83e-05	0.00025	CcSEcCtD
Clonidine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.79e-05	0.000248	CcSEcCtD
Clonidine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.67e-05	0.000242	CcSEcCtD
Clonidine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.66e-05	0.000241	CcSEcCtD
Clonidine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.00024	CcSEcCtD
Clonidine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.00024	CcSEcCtD
Clonidine—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.55e-05	0.000235	CcSEcCtD
Clonidine—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.48e-05	0.000232	CcSEcCtD
Clonidine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000224	CcSEcCtD
Clonidine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.000224	CcSEcCtD
Clonidine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.21e-05	0.000218	CcSEcCtD
Clonidine—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.000217	CcSEcCtD
Clonidine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.15e-05	0.000215	CcSEcCtD
Clonidine—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.03e-05	0.000208	CcSEcCtD
Clonidine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000208	CcSEcCtD
Clonidine—Rash—Epirubicin—peripheral nervous system neoplasm	3.99e-05	0.000207	CcSEcCtD
Clonidine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.99e-05	0.000207	CcSEcCtD
Clonidine—Headache—Epirubicin—peripheral nervous system neoplasm	3.97e-05	0.000205	CcSEcCtD
Clonidine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	0.000201	CcSEcCtD
Clonidine—Nausea—Epirubicin—peripheral nervous system neoplasm	3.76e-05	0.000195	CcSEcCtD
Clonidine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.73e-05	0.000193	CcSEcCtD
Clonidine—Rash—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.000191	CcSEcCtD
Clonidine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.69e-05	0.000191	CcSEcCtD
Clonidine—Headache—Doxorubicin—peripheral nervous system neoplasm	3.67e-05	0.00019	CcSEcCtD
Clonidine—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.48e-05	0.00018	CcSEcCtD
Clonidine—CYP1A1—Metabolism—GNS—peripheral nervous system neoplasm	1.23e-05	0.000775	CbGpPWpGaD
Clonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	1.23e-05	0.000774	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.23e-05	0.000773	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.23e-05	0.000772	CbGpPWpGaD
Clonidine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.22e-05	0.000768	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.21e-05	0.000765	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.21e-05	0.00076	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	1.2e-05	0.000757	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.19e-05	0.000751	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	1.19e-05	0.000749	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.19e-05	0.000748	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—NME1—peripheral nervous system neoplasm	1.18e-05	0.000743	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.18e-05	0.000743	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.15e-05	0.000727	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.15e-05	0.000723	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.14e-05	0.000719	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	1.14e-05	0.000718	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—COX2—peripheral nervous system neoplasm	1.14e-05	0.000716	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—GNAS—peripheral nervous system neoplasm	1.13e-05	0.00071	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.11e-05	0.000701	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.11e-05	0.000699	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.11e-05	0.000697	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.1e-05	0.00069	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.1e-05	0.00069	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.09e-05	0.000688	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.09e-05	0.000684	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.07e-05	0.000675	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.07e-05	0.000675	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—ENO2—peripheral nervous system neoplasm	1.06e-05	0.000668	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.05e-05	0.000665	CbGpPWpGaD
Clonidine—SLC22A1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	1.04e-05	0.000658	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.04e-05	0.000656	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.04e-05	0.000652	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.02e-05	0.000646	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.02e-05	0.000645	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.02e-05	0.00064	CbGpPWpGaD
Clonidine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.01e-05	0.000638	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.01e-05	0.000635	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	9.96e-06	0.000627	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	9.83e-06	0.000619	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	9.73e-06	0.000613	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	9.73e-06	0.000613	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	9.7e-06	0.000611	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	9.58e-06	0.000603	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—PTPN11—peripheral nervous system neoplasm	9.57e-06	0.000603	CbGpPWpGaD
Clonidine—ADRA2B—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	9.51e-06	0.000599	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	9.42e-06	0.000594	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	9.37e-06	0.00059	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	9.26e-06	0.000584	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	9.12e-06	0.000574	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	9.07e-06	0.000571	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	9.04e-06	0.00057	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	9.02e-06	0.000568	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	9.01e-06	0.000567	CbGpPWpGaD
Clonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	8.99e-06	0.000566	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—BCHE—peripheral nervous system neoplasm	8.96e-06	0.000564	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	8.95e-06	0.000564	CbGpPWpGaD
Clonidine—ADRA2C—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	8.88e-06	0.000559	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	8.88e-06	0.000559	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	8.71e-06	0.000548	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—ENO2—peripheral nervous system neoplasm	8.61e-06	0.000543	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—BCHE—peripheral nervous system neoplasm	8.59e-06	0.000541	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	8.55e-06	0.000539	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.55e-06	0.000538	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	8.51e-06	0.000536	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—TH—peripheral nervous system neoplasm	8.42e-06	0.000531	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.38e-06	0.000528	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	8.31e-06	0.000524	CbGpPWpGaD
Clonidine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	8.25e-06	0.000519	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	8.23e-06	0.000518	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.19e-06	0.000516	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	8.08e-06	0.000509	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—TH—peripheral nervous system neoplasm	8.07e-06	0.000509	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	8.02e-06	0.000505	CbGpPWpGaD
Clonidine—SLC22A1—Neuronal System—HRAS—peripheral nervous system neoplasm	8e-06	0.000504	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	7.91e-06	0.000498	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	7.89e-06	0.000497	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	7.85e-06	0.000494	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.8e-06	0.000491	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	7.69e-06	0.000484	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—NRAS—peripheral nervous system neoplasm	7.59e-06	0.000478	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	7.57e-06	0.000477	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	7.52e-06	0.000474	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—ENO2—peripheral nervous system neoplasm	7.46e-06	0.00047	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	7.43e-06	0.000468	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	7.28e-06	0.000458	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	7.24e-06	0.000456	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	7.24e-06	0.000456	CbGpPWpGaD
Clonidine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	7.21e-06	0.000454	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—NRAS—peripheral nervous system neoplasm	7.09e-06	0.000446	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	7.04e-06	0.000443	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.94e-06	0.000437	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—GNAS—peripheral nervous system neoplasm	6.88e-06	0.000433	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	6.84e-06	0.000431	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.82e-06	0.00043	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	6.76e-06	0.000426	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—ABCB1—peripheral nervous system neoplasm	6.75e-06	0.000425	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	6.72e-06	0.000423	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	6.71e-06	0.000423	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	6.67e-06	0.00042	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	6.66e-06	0.000419	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	6.64e-06	0.000418	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—GNAS—peripheral nervous system neoplasm	6.59e-06	0.000415	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	6.58e-06	0.000414	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	6.47e-06	0.000408	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—ABCB1—peripheral nervous system neoplasm	6.47e-06	0.000407	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.36e-06	0.000401	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—BCHE—peripheral nervous system neoplasm	6.3e-06	0.000397	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	6.27e-06	0.000395	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	6.27e-06	0.000395	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	6.24e-06	0.000393	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	6.17e-06	0.000389	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	6.16e-06	0.000388	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	6.06e-06	0.000382	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.01e-06	0.000379	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	5.96e-06	0.000375	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—TH—peripheral nervous system neoplasm	5.92e-06	0.000373	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	5.91e-06	0.000373	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	5.81e-06	0.000366	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—TP53—peripheral nervous system neoplasm	5.8e-06	0.000366	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	5.76e-06	0.000363	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.75e-06	0.000362	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.75e-06	0.000362	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.66e-06	0.000357	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	5.61e-06	0.000354	CbGpPWpGaD
Clonidine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	5.61e-06	0.000353	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	5.59e-06	0.000352	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	5.59e-06	0.000352	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—HRAS—peripheral nervous system neoplasm	5.55e-06	0.00035	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	5.49e-06	0.000346	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	5.48e-06	0.000345	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.48e-06	0.000345	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—TP53—peripheral nervous system neoplasm	5.42e-06	0.000342	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.34e-06	0.000336	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—HRAS—peripheral nervous system neoplasm	5.18e-06	0.000327	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	5.12e-06	0.000322	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.09e-06	0.000321	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	5.03e-06	0.000317	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.03e-06	0.000317	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	5.02e-06	0.000316	CbGpPWpGaD
Clonidine—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	4.9e-06	0.000309	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—GNAS—peripheral nervous system neoplasm	4.84e-06	0.000305	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.82e-06	0.000304	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.8e-06	0.000302	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	4.75e-06	0.0003	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	4.75e-06	0.000299	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	4.74e-06	0.000299	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.74e-06	0.000298	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	4.73e-06	0.000298	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.67e-06	0.000294	CbGpPWpGaD
Clonidine—ADRA2C—Hemostasis—AKT1—peripheral nervous system neoplasm	4.58e-06	0.000288	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.52e-06	0.000285	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	4.46e-06	0.000281	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	4.4e-06	0.000277	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.35e-06	0.000274	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4.28e-06	0.000269	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	4.21e-06	0.000265	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4.07e-06	0.000256	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	4.02e-06	0.000253	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	4e-06	0.000252	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	4e-06	0.000252	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.93e-06	0.000248	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	3.86e-06	0.000243	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.83e-06	0.000241	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	3.78e-06	0.000238	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.74e-06	0.000236	CbGpPWpGaD
Clonidine—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	3.72e-06	0.000234	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	3.67e-06	0.000231	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	3.64e-06	0.000229	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	3.57e-06	0.000225	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.56e-06	0.000224	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.53e-06	0.000222	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.49e-06	0.00022	CbGpPWpGaD
Clonidine—ADRA1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.43e-06	0.000216	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.4e-06	0.000214	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.38e-06	0.000213	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.3e-06	0.000208	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.25e-06	0.000204	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	3.19e-06	0.000201	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.16e-06	0.000199	CbGpPWpGaD
Clonidine—ADRA1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.12e-06	0.000196	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	3.11e-06	0.000196	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.1e-06	0.000195	CbGpPWpGaD
Clonidine—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	3.1e-06	0.000195	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	3.08e-06	0.000194	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	3.07e-06	0.000193	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—AKT1—peripheral nervous system neoplasm	3.04e-06	0.000192	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.03e-06	0.000191	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.98e-06	0.000187	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.96e-06	0.000186	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.93e-06	0.000184	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	2.91e-06	0.000184	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.89e-06	0.000182	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.87e-06	0.000181	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.85e-06	0.000179	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.85e-06	0.000179	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.82e-06	0.000178	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.81e-06	0.000177	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.76e-06	0.000174	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.65e-06	0.000167	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.63e-06	0.000166	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.6e-06	0.000164	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.59e-06	0.000163	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.57e-06	0.000162	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.57e-06	0.000162	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.53e-06	0.000159	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.51e-06	0.000158	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.42e-06	0.000152	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.4e-06	0.000151	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.4e-06	0.000151	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.38e-06	0.00015	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.36e-06	0.000149	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.35e-06	0.000148	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.34e-06	0.000147	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.33e-06	0.000147	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.3e-06	0.000145	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.24e-06	0.000141	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	2.2e-06	0.000139	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.18e-06	0.000137	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.13e-06	0.000134	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.1e-06	0.000132	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.08e-06	0.000131	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.97e-06	0.000124	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.96e-06	0.000123	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.95e-06	0.000123	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.88e-06	0.000119	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	1.86e-06	0.000117	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.84e-06	0.000116	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.84e-06	0.000116	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.82e-06	0.000115	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.81e-06	0.000114	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.78e-06	0.000112	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.76e-06	0.000111	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.73e-06	0.000109	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.66e-06	0.000105	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.61e-06	0.000101	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.55e-06	9.78e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.54e-06	9.68e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.53e-06	9.62e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	1.51e-06	9.5e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.49e-06	9.4e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.43e-06	8.99e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	1.38e-06	8.7e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.36e-06	8.55e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.31e-06	8.22e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.26e-06	7.94e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.04e-06	6.57e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	9.82e-07	6.19e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	8.32e-07	5.24e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	6.42e-07	4.05e-05	CbGpPWpGaD
